Abstract

Abstract Regulatory T cells (T regcells) are responsible for immune homeostasis and highly express PD-1 in the tumor microenvironment (TME). However, the role of PD-1 in tumor-infiltrating (TI) T regcells remains controversial. Indeed, PD-1 expression in T regcells was even higher than in CD8 +T cells and conventional CD4 +T cells. Here, we identified that conditional deletion of PD-1 in T regcells delayed tumor growth by reducing TI T regcell pool and amplifying the functionality of TI CD8 +and CD4 +T cells. In Pdcd1 fl/flFoxp3 eGFP-Cre-ERT2(+/−)mice, in which both PD-1 WTand PD-1 KOT regcells coexisted, TI PD-1 KOT regcells exhibited the impaired proliferative and suppressive capacity compared to TI PD-1 WTT regcells. Additionally, exT regcells, which lost their Foxp3 expression, were more abundant in PD-1 KOT regcells than PD-1 WTT regcells. In TC-1 lung cancer, PD-1 antibody therapy was effective in reducing TI T regcell pool. Single-cell analysis identified that PD-1 signaling promoted various pathways related to lipid metabolism, proliferation, and suppression in TI T regcells. Single-cell TCR sequencing revealed that the clonal expansion of TI T regcells was enriched in PD-1 WTT regcells compared to PD-1 KOT regcells. We also showed that conditional deletion of PD-1 in T regcells reduced lipid uptake and mitochondrial mass of T regcells in TME. These results suggest that PD-1 ablation or blockade can enhance antitumor immunity by exacerbating T regcell stability and metabolic fitness in the TME. This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIT) (2017R1A5A1014560, 2019M3A9B6065221 to S-.J.H.; 2018R1A5A2025079, 2019M3A9B6065192 to I.L.). This study was also supported by the Korean Health Technology R&D Project (HV20C0144, HN21C1410 to S-.J.H.) through the Korean Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call